Aims: To explore health technology assessment (HTA) outcomes of matched drug pairs by national
agencies in Germany (Gemeinsamer Bundesausschuss, GBA), France (Haute Autorité de
Santé, HAS) and England and Wales (NICE). Methods: We considered published ...